Alley Company Has Boosted Position in Abbvie (ABBV); Oakwood Capital Management Trimmed Its Apple (AAPL) Position by $310,787

June 21, 2018 - By Louis Casey

Apple Inc. (NASDAQ:AAPL) Logo

Oakwood Capital Management Llc decreased its stake in Apple Inc (AAPL) by 3.15% based on its latest 2018Q1 regulatory filing with the SEC. Oakwood Capital Management Llc sold 1,861 shares as the company’s stock rose 5.37% while stock markets declined. The institutional investor held 57,301 shares of the computer manufacturing company at the end of 2018Q1, valued at $9.61M, down from 59,162 at the end of the previous reported quarter. Oakwood Capital Management Llc who had been investing in Apple Inc for a number of months, seems to be less bullish one the $911.61 billion market cap company. The stock decreased 0.55% or $1.03 during the last trading session, reaching $185.47. About 12.65M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 22.56% since June 21, 2017 and is uptrending. It has outperformed by 9.99% the S&P500. Some Historical AAPL News: 07/05/2018 – BUFFETT SAYS CHINA AND UNITED STATES HAVE A “COMMON INTEREST” IN AVOIDING TRADE WAR; 25/05/2018 – Bloomberg Markets: GDPR Makes Its EU Debut, Apple’s `Big Win’; 23/03/2018 – The cloud storage company faces some stiff competition in giants like Amazon, Apple, Google and Microsoft; 24/05/2018 – Jury Awards Apple $539 Million in Samsung Patent Case; 27/03/2018 – Apple’s Previous Entry-Level iPad Cost $329; 11/04/2018 – Gartner: HP Had 20.8% Market Share in 1Q, Followed by Lenovo at 20%, Then Dell, Apple, Asus and Acer; 06/04/2018 – MEDIA-Apple hires former Amazon devices CTO for software role – Bloomberg; 25/05/2018 – Apple to Close Atlantic City Store, Cutting 52 Employees; 20/05/2018 – DoT seeks reply from Airtel on Apple Watch eSIM service by May 24; 17/04/2018 – Regina Leader: Apple planning a news subscription service similar to Apple Music

Alley Company Llc increased its stake in Abbvie Inc (ABBV) by 106.81% based on its latest 2018Q1 regulatory filing with the SEC. Alley Company Llc bought 43,884 shares as the company’s stock declined 16.83% with the market. The institutional investor held 84,970 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $8.04M, up from 41,086 at the end of the previous reported quarter. Alley Company Llc who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $145.65 billion market cap company. The stock decreased 2.09% or $2.05 during the last trading session, reaching $96.2. About 3.77M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since June 21, 2017 and is uptrending. It has outperformed by 39.84% the S&P500. Some Historical ABBV News: 05/04/2018 – AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis; 04/05/2018 – STAT Plus: In a message to pharma, one-fifth of AbbVie shareholders support proposal tying pricing risks to exec pay; 05/04/2018 – $ABBV $BIIB Settlement on Humira #Biosimilar in Europe -; 25/05/2018 – Oncolytics Biotech® Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN® with Keytruda®, Velcade® and Dexamethasone; 26/04/2018 – AbbVie 1Q Rev $7.93B; 22/03/2018 – STAT Plus: AbbVie lung cancer results are raising questions about a $6 billion deal; 05/04/2018 – Samsung Bioepis Settles Patent Disputes with AbbVie, Clearing the Way for the Commercialization of SB5 (Adalimumab) in All; 22/05/2018 – AbbVie Donates $100 Million to Strengthen Access to Healthcare, Housing for Hurricane-Ravaged Puerto Rico; 05/04/2018 – BIOGEN INC – PRECISE TERMS OF AGREEMENT WITH ABBVIE ARE CONFIDENTIAL; 05/04/2018 – AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes With Samsung Bioepis

Among 56 analysts covering Apple Inc. (NASDAQ:AAPL), 36 have Buy rating, 1 Sell and 19 Hold. Therefore 64% are positive. Apple Inc. had 421 analyst reports since July 21, 2015 according to SRatingsIntel. Credit Suisse maintained the shares of AAPL in report on Wednesday, July 27 with “Outperform” rating. The stock of Apple Inc. (NASDAQ:AAPL) earned “Buy” rating by UBS on Monday, November 16. The rating was maintained by Mizuho with “Hold” on Monday, September 18. The company was maintained on Monday, August 24 by FBR Capital. The stock has “Hold” rating by Deutsche Bank on Wednesday, August 2. The stock of Apple Inc. (NASDAQ:AAPL) earned “Outperform” rating by RBC Capital Markets on Thursday, August 11. The firm earned “Buy” rating on Friday, May 26 by Piper Jaffray. The company was maintained on Friday, January 8 by Cowen & Co. The stock of Apple Inc. (NASDAQ:AAPL) earned “Buy” rating by Brean Capital on Wednesday, October 26. The rating was maintained by Nomura on Wednesday, September 13 with “Buy”.

Oakwood Capital Management Llc, which manages about $705.78M and $234.25 million US Long portfolio, upped its stake in Schlumberger Ltd. (NYSE:SLB) by 8,268 shares to 53,453 shares, valued at $3.46M in 2018Q1, according to the filing.

Investors sentiment decreased to 0.69 in 2018 Q1. Its down 0.04, from 0.73 in 2017Q4. It turned negative, as 69 investors sold AAPL shares while 1039 reduced holdings. 125 funds opened positions while 645 raised stakes. 2.86 billion shares or 3.74% less from 2.98 billion shares in 2017Q4 were reported. Howard Cap Management reported 162,084 shares. Gamble Jones Counsel invested in 2.78% or 166,372 shares. Private Advsr Inc invested 4.17% in Apple Inc. (NASDAQ:AAPL). The Michigan-based Regal Inv Advisors Limited Company has invested 1.3% in Apple Inc. (NASDAQ:AAPL). Pioneer Trust Bankshares N A Or reported 4.25% of its portfolio in Apple Inc. (NASDAQ:AAPL). Fairview Cap Mngmt Ltd Llc owns 12,644 shares for 0.13% of their portfolio. Usa Financial Portformulas holds 1.61% or 39,713 shares in its portfolio. Comerica Securities invested in 35,603 shares. Gp Incorporated has invested 1.09% in Apple Inc. (NASDAQ:AAPL). Da Davidson And Company holds 417,165 shares or 1.45% of its portfolio. Lehman Financial Resource has 0.46% invested in Apple Inc. (NASDAQ:AAPL) for 5,359 shares. Consolidated Group Limited Liability Com holds 2.98% or 36,757 shares. Willow Creek Wealth Management stated it has 1.38% in Apple Inc. (NASDAQ:AAPL). Foster And Motley Inc reported 2.59% stake. Glovista Invs Limited invested 0.16% of its portfolio in Apple Inc. (NASDAQ:AAPL).

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Livetradingnews.com which released: “Apple Inc. (NASDAQ:AAPL) Ramping up Content Deals” on June 19, 2018, also Nasdaq.com with their article: “Don’t Throw Out Starbucks Stock Based on One Bad Serving of News” published on June 20, 2018, Seekingalpha.com published: “Bloomberg: Apple’s delayed charging mat could launch in September” on June 21, 2018. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Seekingalpha.com and their article: “My #1 Stock In The World: Apple” published on June 19, 2018 as well as Seekingalpha.com‘s news article titled: “Apple: Can Shares Double Again In 2 Years?” with publication date: June 13, 2018.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on August, 7. They expect $2.19 earnings per share, up 31.14% or $0.52 from last year’s $1.67 per share. AAPL’s profit will be $10.76 billion for 21.17 P/E if the $2.19 EPS becomes a reality. After $2.73 actual earnings per share reported by Apple Inc. for the previous quarter, Wall Street now forecasts -19.78% negative EPS growth.

Since January 5, 2018, it had 0 buys, and 13 sales for $52.34 million activity. LEVINSON ARTHUR D sold $6.51 million worth of stock. Shares for $6.75 million were sold by AHRENDTS ANGELA J on Thursday, May 3. $2.99M worth of Apple Inc. (NASDAQ:AAPL) was sold by WILLIAMS JEFFREY E. On Tuesday, April 3 SCHILLER PHILIP W sold $11.56 million worth of Apple Inc. (NASDAQ:AAPL) or 69,491 shares. On Wednesday, May 16 the insider KONDO CHRIS sold $910,129. Another trade for 15,641 shares valued at $2.73M was sold by Riccio Daniel J..

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie: Forget Humira Concerns And Hold On To This Pharma Giant” on June 18, 2018, also Seekingalpha.com with their article: “Translate Bio readies IPO” published on June 02, 2018, Seekingalpha.com published: “Premarket analyst action – healthcare” on May 24, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Fool.com and their article: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” published on June 20, 2018 as well as Seekingalpha.com‘s news article titled: “More Thoughts On AbbVie’s Rova-T Implosion” with publication date: June 06, 2018.

Since February 19, 2018, it had 0 insider buys, and 10 sales for $26.80 million activity. Shares for $9.57 million were sold by ALBAN CARLOS. The insider Schumacher Laura J sold 25,000 shares worth $2.95 million. $8.31 million worth of stock was sold by CHASE WILLIAM J on Wednesday, February 28. $2.15M worth of AbbVie Inc. (NYSE:ABBV) was sold by RICHMOND TIMOTHY J. on Wednesday, February 28. Michael Robert A. sold $119,351 worth of stock or 992 shares. 1,337 shares valued at $157,458 were sold by SALEKI-GERHARDT AZITA on Wednesday, February 28.

Among 24 analysts covering Abbvie Inc (NYSE:ABBV), 9 have Buy rating, 3 Sell and 12 Hold. Therefore 38% are positive. Abbvie Inc had 96 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, January 16 by Jefferies. Cowen & Co downgraded the shares of ABBV in report on Monday, June 6 to “Market Perform” rating. The rating was maintained by BMO Capital Markets with “Underperform” on Wednesday, May 23. The firm earned “Market Perform” rating on Thursday, November 16 by BMO Capital Markets. The company was maintained on Thursday, January 4 by Jefferies. The rating was initiated by Raymond James on Friday, September 2 with “Outperform”. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Cowen & Co on Monday, November 20. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Thursday, September 28 by Deutsche Bank. SunTrust maintained AbbVie Inc. (NYSE:ABBV) rating on Sunday, October 29. SunTrust has “Buy” rating and $105.0 target. Cowen & Co maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, July 28. Cowen & Co has “Hold” rating and $7000 target.

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>